Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001408337 | SCV001610335 | likely benign | Tuberous sclerosis 2 | 2024-03-13 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004006911 | SCV004831596 | likely benign | Tuberous sclerosis syndrome | 2023-06-26 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV003151313 | SCV003839175 | likely benign | not specified | 2022-12-22 | no assertion criteria provided | clinical testing | DNA sequence analysis of the TSC2 gene demonstrated a sequence change in intron 40, c.5161-10A>G. This change does not appear to have been previously described in individuals with TSC2-related disorders and has also not been described in population databases such as ExAC and gnomAD. This sequence change is not predicted to have a deleterious effect on splicing based on in-silico splice prediction programs. It is possible that this sequence change represents a benign sequence change in the TSC2 gene that has not been identified to date. The functional significance of this sequence change is not known at present and its contribution to this individual's disease phenotype cannot definitively be determined. |